Rennova Health, Inc. (RNVA)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 21, 2025, 4:00 PM EST
Rennova Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Revenue | 20.3 | 13.04 | 3.22 | 7.2 | 16 | 14.55 | Upgrade
|
| Revenue Growth (YoY) | 113.44% | 304.36% | -55.22% | -55.01% | 10.00% | 371.10% | Upgrade
|
| Cost of Revenue | 7.49 | 6.77 | 5.29 | 11.78 | 14.76 | 11.51 | Upgrade
|
| Gross Profit | 12.81 | 6.27 | -2.07 | -4.58 | 1.24 | 3.04 | Upgrade
|
| Selling, General & Admin | 8.8 | 7.21 | 7.51 | 11.66 | 15.9 | 14.83 | Upgrade
|
| Operating Expenses | 9.17 | 7.68 | 8.15 | 12.36 | 16.69 | 16.09 | Upgrade
|
| Operating Income | 3.65 | -1.41 | -10.22 | -16.95 | -15.45 | -13.05 | Upgrade
|
| Interest Expense | -2.02 | -2.26 | -3.19 | -9.84 | -21.73 | -21.53 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.42 | -0.09 | 1.25 | -2.64 | -2.51 | 13.7 | Upgrade
|
| EBT Excluding Unusual Items | 2.04 | -3.76 | -12.16 | -29.43 | -39.69 | -20.89 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.25 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | -0 | -0.27 | -0.01 | - | 0.67 | Upgrade
|
| Asset Writedown | - | - | -2.3 | -0.25 | - | -0.17 | Upgrade
|
| Legal Settlements | 0.17 | -0.13 | 3.25 | 0.67 | - | - | Upgrade
|
| Other Unusual Items | 0.8 | 0.93 | 6.39 | 10.06 | -6.64 | 7.57 | Upgrade
|
| Pretax Income | 3.01 | -2.96 | -5.09 | -18.95 | -46.58 | -12.82 | Upgrade
|
| Income Tax Expense | 0.65 | 0.31 | 0.18 | -1.31 | - | 0.77 | Upgrade
|
| Earnings From Continuing Operations | 2.37 | -3.27 | -5.27 | -17.64 | -46.58 | -13.59 | Upgrade
|
| Earnings From Discontinued Operations | -0.02 | -0.02 | 10.88 | -0.7 | -1.45 | -0.43 | Upgrade
|
| Net Income | 2.36 | -3.29 | 5.61 | -18.34 | -48.03 | -14.02 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 330.88 | 506.48 | 263.25 | 123.86 | 231.84 | Upgrade
|
| Net Income to Common | 2.36 | -334.17 | -500.87 | -281.59 | -171.9 | -245.87 | Upgrade
|
| Shares Outstanding (Basic) | 29,671 | 9,992 | 1 | - | - | - | Upgrade
|
| Shares Outstanding (Diluted) | 384,187 | 9,992 | 1 | - | - | - | Upgrade
|
| Shares Change (YoY) | 12298.36% | 1822047.62% | - | - | - | - | Upgrade
|
| EPS (Basic) | 0.00 | -0.03 | -913.37 | - | - | - | Upgrade
|
| EPS (Diluted) | -0.00 | -0.03 | -913.37 | - | - | - | Upgrade
|
| Free Cash Flow | 3.73 | -0.25 | -8.91 | -17.3 | -13.53 | -7.89 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | -0.00 | -16.25 | - | - | - | Upgrade
|
| Gross Margin | 63.10% | 48.08% | -64.16% | -63.66% | 7.77% | 20.89% | Upgrade
|
| Operating Margin | 17.96% | -10.81% | -317.00% | -235.35% | -96.54% | -89.70% | Upgrade
|
| Profit Margin | 11.60% | -2563.40% | -15536.23% | -3910.97% | -1074.12% | -1689.95% | Upgrade
|
| Free Cash Flow Margin | 18.36% | -1.95% | -276.46% | -240.26% | -84.54% | -54.24% | Upgrade
|
| EBITDA | 4.01 | -0.94 | -9.58 | -16.24 | -14.65 | -11.79 | Upgrade
|
| EBITDA Margin | 19.77% | -7.21% | -297.04% | -225.61% | -91.57% | -81.02% | Upgrade
|
| D&A For EBITDA | 0.37 | 0.47 | 0.64 | 0.7 | 0.8 | 1.26 | Upgrade
|
| EBIT | 3.65 | -1.41 | -10.22 | -16.95 | -15.45 | -13.05 | Upgrade
|
| EBIT Margin | 17.96% | -10.81% | - | -235.35% | -96.54% | -89.70% | Upgrade
|
| Effective Tax Rate | 21.43% | - | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.